InvestorsHub Logo
Followers 68
Posts 2644
Boards Moderated 0
Alias Born 08/20/2013

Re: None

Monday, 02/03/2014 5:09:44 PM

Monday, February 03, 2014 5:09:44 PM

Post# of 977
Looking to get in here if it dips below .40. CD47 therapy has proven strong results in cancer treatment, according to the latest University of Stanford studies. Lots of institutional money in this play already, and the company has over $30M in cash. Market dynamics might provide a sincerely profitable long-term entry price.